Loading stock data…
SRTA
$5.08+0.06 (+1.20%)
Market ClosedLast close May 1
Strata Critical Medical, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Strata Critical Medical, Inc. in the Healthcare sector is trading at $5.08. The stock is currently 16% below its 52-week high of $6.02, remaining 8.1% above its 200-day moving average. Technical signals show overbought RSI of 75 and bullish MACD crossover, explaining why SRTA maintains its current momentum and trend strength. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Overbought levels (RSI 75) — risk of consolidation or pullback
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$5.08
Potential Upside
5%
Whystock Fair Value$5.33
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground tr...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$414.08M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.11
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-13.23%
Volume
Today's trading volume
424,512
Recent News
How The Story Is Shifting For Strata Critical Medical (SRTA) After The Lower Fair Value Target
The analyst fair value target for Strata Critical Medical has shifted from US$9.63 to US$8.81, pointing to a more measured view of where the shares might reasonably trade. This revision sits alongside largely constructive research coverage, with firms updating their models while still focusing on how well management delivers against its current plan. As you read on, you will see how this evolving price target fits into the broader story and what to watch as the narrative develops. Analyst...
Niagen Bioscience And 2 Additional Promising Penny Stocks For Your Consideration
Over the last 7 days, the United States market has risen by 4.4%, and in the past year, it has climbed an impressive 32%, with earnings expected to grow by 16% annually. While penny stocks might seem like a relic from earlier market times, they continue to represent smaller or less-established companies that can offer significant value when chosen wisely. By focusing on those with strong financials and clear growth potential, investors can uncover opportunities in these niche stocks that may...
Cathie Wood’s Ark keeps selling one stock once again
Cathie Wood, head of Ark Investment Management, is known for making bold, conviction-driven bets, but she’s just as quick to trim positions when the strategy shifts. That pattern is playing out again this week. ARK Investment Management has continued selling shares of Strata Critical Medical ...
Cathie Wood Dumps $10 Million of Mega Chip Stock
Cathie Wood Trims AMD Position as Market Momentum Shifts
Strata Critical Medical, Inc. Q4 2025 Earnings Call Summary
Moby summary of Strata Critical Medical, Inc.'s Q4 2025 earnings call